查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1198697

導尿管市場 - COVID-19 的增長、趨勢、影響和預測 (2023-2028)

Urinary Catheters Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 112 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022-2027 年的預測期內，導尿管市場預計將以近 5.5% 的複合年增長率增長。

導尿管市場預計將受到 COVID-19 情景的深刻影響。 隨著病例數量仍在上升，以及一些患有 COVID-19 的危重患者使用導尿管，預計對導尿管的需求也會增加。 預計這將對導尿管的需求產生積極影響。

推動導尿管市場增長的主要因素包括尿失禁患病率上升、老年人口增加以及導尿管材料技術進步。

增加的資金將支持在市場上推出更多創新產品。 例如，2020 年 12 月，Ingenion Medical Ltd 從 Innovative UK 獲得了約 10 萬英鎊的資金，用於開發產品 CymActive 導尿管。 這是一種新型醫療器械，旨在治療男性尿瀦留患者。 尿失禁是一種診斷不足和報告不足的疾病，可能會隨著年齡的增長而增加，主要影響老年人。 此外，根據世界老齡化人口報告，2019年，約有7.029億人超過65歲，預計到2050年這一數字將達到15.489億。 因此，這有望推動市場增長。

導尿管市場趨勢

良性前列腺增生症 (BPH) 預計在預測期內顯示導尿管市場顯著增長

預計在預測期內，良性前列腺增生 (BPH) 將在導尿管市場出現顯著增長。 然而，隨著 COVID-19 的爆發，BPH 的診斷和治療出現延誤。 這對該細分市場所研究的市場產生了總體負面影響。 根據 2020 年 6 月發表的“Gravas S, Fournier G, Oya M, et al. Prioritizing urological surgery in the COVID-19 era: a global reflection on guidelines”的研究，對 76 個國家的約 2,494 名泌尿科醫生進行了調查，BPH 是在非腫瘤治療中被列為最低的治療優先級。

BPH 在老年男性中很常見。 2020 年 5 月發表的一項題為“提示老年男性良性前列腺增生的下尿路症狀患病率及相關因素”的研究發現，隨著人口老齡化，BPH 患病率在中國人群中也會增加。正在上升。 BPH常伴有尿失禁、尿頻、排尿困難等症狀。 因此，良性前列腺增生的增加預計將影響尿失禁的總體負擔並推動該領域的市場增長。

北美市場份額最大

北美在導尿管市場中佔有很大份額，預計在預測期內也將呈現類似趨勢。 預計 COVID-19 的爆發將對市場產生重大影響。 2021 年 2 月，加拿大衛生部批准了 Bactguard 設計的 TempSensor 導管。 由於一些重症 COVID-19 患者使用了導尿管，因此此類產品的推出可能會對所研究的市場產生積極影響。

不斷增加的尿失禁負擔和不斷增長的老年人口正在推動該地區的市場。 根據泌尿外科護理基金會 2019 年修訂版，美國三分之一的男性和女性患有尿失禁。 大約有 3300 萬人患有膀胱過度活動症，表現為伴有或不伴有尿急、尿頻和急迫性尿失禁。

此外，技術先進產品的推出有望在預測期內推動該地區的市場發展。 例如，2019 年 2 月，Safe Medical Design Inc. 的產品 Signal Catheter 獲得了美國食品和藥物管理局 (US FDA) 的批准。 因此，上述因素有望對市場增長產生積極影響。

導尿管市場競爭者分析

導尿管市場相當分散，有一些大大小小的參與者。 市場進入者專注於研發，為市場開發技術先進的產品。 新進入者的壁壘很高，少數大公司佔據最大份額。 主要參與者包括 B Braun Melsungen AG、Boston Scientific Corporation、Teleflex Inc. 和 Medtronic PLC。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第一章介紹

  • 研究假設和市場定義
  • 調查範圍

第二章研究方法論

第 3 章執行摘要

第四章市場動態

  • 市場概覽
  • 市場驅動因素
    • 尿失禁患病率上升
    • 老年人口增加
    • 導管所用材料的技術進步
  • 市場製約因素
    • 導尿管相關尿路感染 (CAUTI) 的風險
    • 尿失禁的替代療法
  • 行業吸引力 - 波特五力分析
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模：100 萬美元）

  • 按產品類型
    • 留置（Foley）導管
    • 間歇性導尿管
    • 體外導管
  • 通過申請
    • 良性前列腺增生症 (BPH)
    • 尿失禁
    • 脊髓損傷
    • 其他用途
  • 區域信息
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東
      • 海灣合作委員會
      • 南非
      • 其他中東地區
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章競爭格局

  • 公司簡介
    • Amsino International Inc.
    • B Braun Melsungen AG
    • Boston Scientific Corporation
    • Coloplast AS
    • ConvaTec Group PLC
    • Cook Medical
    • Cure Medical LLC
    • Hollister Incorporated
    • Medtronic PLC
    • Teleflex Incorporated
    • C R Bard
    • Beckton Dickinson and Company
    • ASID BONZ GmbH
    • CompactCath
    • Go Medical Industries Pty Ltd

第7章 市場機會今後動向

簡介目錄
Product Code: 60487

The urinary catheters market is expected to register a CAGR of nearly 5.5% during the forecast period of 2022-2027.

A profound impact on the urinary catheter market is expected due to the COVID-19 scenario. As the number of cases is still on the rise, the demand for urinary catheters is also expected to increase since urinary catheters are used in some critically ill patients suffering from COVID-19. Thus, this is expected to impact the demand for urinary catheters positively.

The primary factors driving the growth of the urinary catheter market include the rising prevalence of urinary incontinence, the growing geriatric population, and technological advancement in the material used for catheters.

Increasing funding provides support for more innovative product launches in the market. For instance, in December 2020, Ingenion Medical Ltd received about GBP 100,000 funding from the Innovative UK to develop its product CymActive urinary catheter. It is a novel medical device that is designed for treating male patients suffering from urinary retention. Urinary incontinence is an underdiagnosed and underreported condition that is likely to increase with age and majorly affects the elderly population. Furthermore, as per the World Ageing Population report, in 2019, about 702.9 million people living were aged 65 years and above, and this number is expected to reach 1,548.9 million by 2050. Thus, this is expected to fuel the market growth.

Urinary Catheters Market Trends

Benign Prostate Hyperplasia (BPH) is Expected to Show a Significant Growth in the Urinary Catheter Market During the Forecast Period

Benign prostate hyperplasia (BPH) is expected to show significant growth in the urinary catheter market during the forecast period. However, with the COVID-19 outbreak, a delay in diagnosis and treatment was observed in the case of BPH. This overall impacted negatively on the market studied in this segment. As per the study 'Gravas S, Fournier G, Oya M, et al. Prioritising urological surgery in the COVID-19 era: a global reflection on guidelines', published in June 2020, about 2,494 urologists were surveyed from 76 countries wherein BPH was preferred as one of the lowest priorities in terms of treatment in non-oncological procedures.

BPH is a very common condition among older men. A study titled, 'The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males', published in May 2020, revealed that with increasing aging, the prevalence of BPH also increased among the Chinese population. BPH is often associated with the conditions such as urinary incontinence, frequent urination, and urine initiation difficulties. Thus, the growing burden of BPH is further expected to impact the overall burden of urinary incontinence, thereby flourishing the market growth in this segment.

North America Accounted for the Largest Share in the Market

North America occupied a major share in the urinary catheter market, and the region is expected to show a similar trend over the forecast period. A profound impact is expected on the market due to the COVID-19 outbreak. In February 2021, Health Canada approved the TempSensor catheter designed by Bactguard. As urinary catheters are being used in some cases of critically ill COVID-19 patients, the introduction of such products can positively impact the market studied.

The growing burden of urinary incontinence and the rising geriatric population are some of the driving factors in this region for the market studied. According to the Urology Care Foundation, 2019 revision, one-third of men and women in the United States suffer from urinary incontinence. About 33 million have overactive bladders, representing symptoms of urgency, frequency, and with or without urge incontinence.

Furthermore, with the introduction of technologically advanced products, the market in this region is expected to fuel over the forecast period. For instance, in February 2019, Safe Medical Design Inc. received approval from the United States Food & Drug Administration (US FDA) for its product Signal Catheter. Thus, the factors mentioned above are expected to impact the market growth positively.

Urinary Catheters Market Competitor Analysis

The urinary catheter market is moderately fragmented, with the presence of a few major players and small players. The market players are focusing on R&D to develop technologically advanced products in the market. The barriers for the new entrants are high in this industry, and hence, few major market players hold the maximum market share. Some of the major players in the market are B Braun Melsungen AG, Boston Scientific Corporation, Teleflex Inc., and Medtronic PLC, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Urinary Incontinence
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Technological Advancement in the Material Used for Catheters
  • 4.3 Market Restraints
    • 4.3.1 Risk of Catheter-associated Urinary Tract Infection (CAUTI)
    • 4.3.2 Alternative Treatment Options for Urinary Incontinence
  • 4.4 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Buyers/Consumers
    • 4.4.2 Bargaining Power of Suppliers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product Type
    • 5.1.1 Indwelling (Foley) Catheters
    • 5.1.2 Intermittent Catheters
    • 5.1.3 External Catheters
  • 5.2 By Application
    • 5.2.1 Benign Prostate Hyperplasia (BPH)
    • 5.2.2 Urinary Incontinence
    • 5.2.3 Spinal Cord Injury
    • 5.2.4 Other Applications
  • 5.3 By Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Amsino International Inc.
    • 6.1.2 B Braun Melsungen AG
    • 6.1.3 Boston Scientific Corporation
    • 6.1.4 Coloplast AS
    • 6.1.5 ConvaTec Group PLC
    • 6.1.6 Cook Medical
    • 6.1.7 Cure Medical LLC
    • 6.1.8 Hollister Incorporated
    • 6.1.9 Medtronic PLC
    • 6.1.10 Teleflex Incorporated
    • 6.1.11 C R Bard
    • 6.1.12 Beckton Dickinson and Company
    • 6.1.13 ASID BONZ GmbH
    • 6.1.14 CompactCath
    • 6.1.15 Go Medical Industries Pty Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS